The Maria Sklodowska-Curie National Research Institute of Oncology is a specialized research institute and hospital of the Polish Ministry of Health. Based in Warsaw, it also has regional branches in Gliwice and Kraków.

During the past decade, Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit" are "Cervical Cancer" (1 trials), "Endometrial Neoplasms" (1 trials), "Fallopian Tube Cancer" (1 trials), "High-grade Serous Ovarian Carcinoma" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit" in a lesser frequency.

Most popular intervention types in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Atezolizumab Placebo" (1 trials) and "Avastin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit" are 4 trials for "Female" genders.

Currently, there are NaN active trials in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".